Back to today’s briefing

Story perspectives

UK Launches Gonorrhoea Vaccine Amid Surging Cases

5/23/2025

31 7

Summary

Story summary

The UK is set to roll out a groundbreaking vaccine aimed at preventing gonorrhoea, focusing on high-risk groups via the NHS. With an effectiveness rate of 32.7% to 42%, this initiative comes as gonorrhoea cases in Europe surged by 31% in 2023, underscoring a critical need for action. However, it won't be available in mainland Europe due to regulatory hurdles.

1 of 1

Story summary

The UK is set to roll out a groundbreaking vaccine aimed at preventing gonorrhoea, focusing on high-risk groups via the NHS. With an effectiveness rate of 32.7% to 42%, this initiative comes as gonorrhoea cases in Europe surged by 31% in 2023, underscoring a critical need for action. However, it won't be available in mainland Europe due to regulatory hurdles.